Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLoose stools and diarrhoea are among the most commonly reported side effects when starting or moving up to Mounjaro 5mg, and they are also among the most misunderstood. Most people find they settle within one to two weeks as the body adjusts to the new dose. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your full medical picture before it is dispensed, and any side effects you experience should be discussed with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows how quickly food moves from the stomach into the small intestine. At 2.5mg the effect is relatively gentle; at 5mg the brake is applied more firmly, and for some people the gut protests. The result can be looser, more frequent stools, sometimes within a day or two of the first 5mg injection.
A common misconception is that diarrhoea means the medicine is not working or that the dose is wrong. In most cases it simply means the digestive system is still calibrating. The 5mg pen is the first therapeutic step after the starter 2.5mg dose, and the GI symptoms that accompany it are broadly the same pattern reported across the SURMOUNT clinical trials, documented in detail on the NHS tirzepatide medicines page.
What can make things worse: eating large meals, high-fat foods, or very spicy food straight after an injection. The slowed gastric emptying means the gut is already working harder than usual, and a heavy meal on top amplifies that. Smaller, lower-fat meals in the 24 hours after your injection day can take the edge off.
Hydration comes first. Loose stools lose more fluid than most people realise, and because Mounjaro already suppresses appetite you may also be drinking less than usual. Water, diluted squash, and clear broths all help. If you are losing fluid rapidly, oral rehydration sachets (widely available at pharmacies) replace the salts lost alongside water.
Eating habits matter more than most people expect at this stage. Keeping portions modest, choosing lower-fat proteins, and spacing meals through the day gives the slowed gut a more manageable workload. It is also worth noting that some people find dairy or high-fibre foods harder to tolerate in the first weeks at a new dose, a temporary adjustment rather than a permanent restriction.
If you moved up from 2.5mg and noticed similar symptoms then, revisiting what helped you at that stage is a reasonable starting point. Some patients find early diarrhoea at the 2.5mg stage gave them a useful template for managing the 5mg transition. Keep a brief note of when loose stools occur relative to your injection day, this is useful information for your prescriber if the pattern persists.
Most diarrhoea on Mounjaro 5mg is mild-to-moderate and self-limiting. There are specific patterns, though, that require you to contact a doctor or call 111 promptly.
Persistent or severe diarrhoea that is causing dehydration is one. Signs of dehydration include passing very little or no urine, a dry mouth, dizziness, or a fast heartbeat. If you cannot keep fluids down, do not wait, get medical advice the same day.
Severe abdominal pain is another red flag. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. The hallmark symptom is intense, persistent stomach pain that reaches toward the back, sometimes accompanied by vomiting. Stop the injection and seek urgent care if this happens. You can find the full MHRA guidance on the Yellow Card reporting site, and reporting your own experience there helps regulators track these patterns across the wider patient population.
Bloody stools, a high fever alongside diarrhoea, or symptoms that are getting steadily worse rather than settling after two weeks should all be reviewed by a clinician. If you are unsure, contact your prescriber or ring 111.
If diarrhoea is persistent beyond two weeks at 5mg, or if it is affecting your daily life, talk to the prescriber before your next injection. Options they may consider include a longer time at the current dose before any future increase, or reviewing whether the dose is right for you. Some patients also find that understanding how the 5mg dose is used in the titration schedule helps them set realistic expectations.
Never adjust your own dose or timing based on side effects alone. That decision belongs to your prescriber, who has your full history and can weigh the benefit against what you are experiencing. At nume, our clinical team includes GPhC-registered Independent Prescribers who review every repeat order; if your side effects have changed since your last review, flag this through our aftercare team and they will pass it to a prescriber the same day.
For those thinking about what comes next in the titration schedule, it is worth knowing that diarrhoea patterns at 7.5mg follow a broadly similar course to 5mg, though individual responses vary. Our prescribers discuss suitability for each dose increase as part of the clinical review, and you can read a full overview of how Mounjaro works as a weight loss treatment if you would like to check your eligibility, you can start a free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.